Assessment of classification improvement in patients with Alzheimer's disease based on magnetoencephalogram blind source separation

EEG Signal Complexity Measurements to Enhance BCI-Based Stroke Patients' Rehabilitation

The second leading cause of death and one of the most common causes of disability in the world is stroke. Researchers have found that brain-computer interface (BCI) techniques can result in better stroke patient rehabilitation. This study used the proposed motor imagery (MI) framework to analyze the electroencephalogram (EEG) dataset from eight subjects in order to enhance the MI-based BCI systems for stroke patients. The preprocessing portion of the framework comprises the use of conventional filters and the independent component analysis (ICA) denoising approach. Fractal dimension (FD) and Hurst exponent (Hur) were then calculated as complexity features, and Tsallis entropy (TsEn) and dispersion entropy (DispEn) were assessed as irregularity parameters. The MI-based BCI features were then statistically retrieved from each participant using two-way analysis of variance (ANOVA) to demonstrate the individuals' performances from four classes (left hand, right hand, foot, and tongue). The dimensionality reduction algorithm, Laplacian Eigenmap (LE), was used to enhance the MI-based BCI classification performance. Utilizing k-nearest neighbors (KNN), support vector machine (SVM), and random forest (RF) classifiers, the groups of post-stroke patients were ultimately determined. The findings show that LE with RF and KNN obtained 74.48% and 73.20% accuracy, respectively; therefore, the integrated set of the proposed features along with ICA denoising technique can exactly describe the proposed MI framework, which may be used to explore the four classes of MI-based BCI rehabilitation. This study will help clinicians, doctors, and technicians make a good rehabilitation program for people who have had a stroke.

Routine magnetoencephalography in memory clinic patients: A machine learning approach

INTRODUCTION

We report the routine application of magnetoencephalography (MEG) in a memory clinic, and its value in the discrimination of patients with Alzheimer's disease (AD) dementia from controls.

METHODS

Three hundred sixty-six patients visiting our memory clinic underwent MEG recording. Source-reconstructed MEG data were visually assessed and evaluated in the context of clinical findings and other diagnostic markers. We analyzed the diagnostic accuracy of MEG spectral measures in the discrimination of individual AD dementia patients (n = 40) from subjective cognitive decline (SCD) patients (n = 40) using random forest models.

RESULTS

Best discrimination was obtained using a combination of relative theta and delta power (accuracy 0.846, sensitivity 0.855, specificity 0.837). The results were validated in an independent cohort. Hippocampal and thalamic regions, besides temporal-occipital lobes, contributed considerably to the model.

DISCUSSION

MEG has been implemented successfully in the workup of memory clinic patients and has value in diagnostic decision-making.

An Overview of ICA/BSS-Based Application to Alzheimer's Brain Signal Processing

Alzheimer's disease (AD) is by far the most common cause of dementia associated with aging. Early and accurate diagnosis of AD and ability to track progression of the disease is increasingly important as potential disease-modifying therapies move through clinical trials. With the advent of biomedical techniques, such as computerized tomography (CT), electroencephalography (EEG), magnetoencephalography (MEG), positron emission tomography (PET), magnetic resonance imaging (MRI), and functional magnetic resonance imaging (fMRI), large amounts of data from Alzheimer's patients have been acquired and processed from which AD-related information or "signals" can be assessed for AD diagnosis. It remains unknown how best to mine complex information from these brain signals to aid in early diagnosis of AD. An increasingly popular technique for processing brain signals is independent component analysis or blind source separation (ICA/BSS) that separates blindly observed signals into original signals that are as independent as possible. This overview focuses on ICA/BSS-based applications to AD brain signal processing.

Permutation Entropy and Statistical Complexity in Mild Cognitive Impairment and Alzheimer's Disease: An Analysis Based on Frequency Bands

We present one of the first applications of Permutation Entropy (PE) and Statistical Complexity (SC) (measured as the product of PE and Jensen-Shanon Divergence) on Magnetoencephalography (MEG) recordings of 46 subjects suffering from Mild Cognitive Impairment (MCI), 17 individuals diagnosed with Alzheimer's Disease (AD) and 48 healthy controls. We studied the differences in PE and SC in broadband signals and their decomposition into frequency bands ( δ , θ , α and β ), considering two modalities: (i) raw time series obtained from the magnetometers and (ii) a reconstruction into cortical sources or regions of interest (ROIs). We conducted our analyses at three levels: (i) at the group level we compared SC in each frequency band and modality between groups; (ii) at the individual level we compared how the [PE, SC] plane differs in each modality; and (iii) at the local level we explored differences in scalp and cortical space. We recovered classical results that considered only broadband signals and found a nontrivial pattern of alterations in each frequency band, showing that SC does not necessarily decrease in AD or MCI.

Magnetoencephalography applied to the study of Alzheimer's disease

Magnetoencephalography (MEG) is a relatively modern neuroimaging technique able to study normal and pathological brain functioning with temporal resolution in the order of milliseconds and adequate spatial resolution. Although its clinical applications are still relatively limited, great advances have been made in recent years in the field of dementia and Alzheimer's disease (AD) in particular. In this chapter, we briefly describe the physiological phenomena underlying MEG brain signals and the different metrics that can be computed from these data in order to study the alterations disrupting brain activity not only in demented patients, but also in the preclinical and prodromal stages of the disease. Changes in non-linear brain dynamics, power spectral properties, functional connectivity and network topological changes observed in AD are narratively summarized in the context of the pathophysiology of the disease. Furthermore, the potential of MEG as a potential biomarker to identify AD pathology before dementia onset is discussed in the light of current knowledge and the relationship between potential MEG biomarkers and current established hallmarks of the disease is also reviewed. To this aim, findings from different approaches such as resting state or during the performance of different cognitive paradigms are discussed.Lastly, there is an increasing interest in current scientific literature in promoting interventions aimed at modifying certain lifestyles, such as nutrition or physical activity among others, thought to reduce or delay AD risk. We discuss the utility of MEG as a potential marker of the success of such interventions from the available literature.

A Comprehensive Review of Magnetoencephalography (MEG) Studies for Brain Functionality in Healthy Aging and Alzheimer's Disease (AD)

Neural oscillations were established with their association with neurophysiological activities and the altered rhythmic patterns are believed to be linked directly to the progression of cognitive decline. Magnetoencephalography (MEG) is a non-invasive technique to record such neuronal activity due to excellent temporal and fair amount of spatial resolution. Single channel, connectivity as well as brain network analysis using MEG data in resting state and task-based experiments were analyzed from existing literature. Single channel analysis studies reported a less complex, more regular and predictable oscillations in Alzheimer's disease (AD) primarily in the left parietal, temporal and occipital regions. Investigations on both functional connectivity (FC) and effective (EC) connectivity analysis demonstrated a loss of connectivity in AD compared to healthy control (HC) subjects found in higher frequency bands. It has been reported from multiplex network of MEG study in AD in the affected regions of hippocampus, posterior default mode network (DMN) and occipital areas, however, conclusions cannot be drawn due to limited availability of clinical literature. Potential utilization of high spatial resolution in MEG likely to provide information related to in-depth brain functioning and underlying factors responsible for changes in neuronal waves in AD. This review is a comprehensive report to investigate diagnostic biomarkers for AD may be identified by from MEG data. It is also important to note that MEG data can also be utilized for the same pursuit in combination with other imaging modalities.

Automatic Artifact Removal in EEG of Normal and Demented Individuals Using ICA-WT during Working Memory Tasks

Characterizing dementia is a global challenge in supporting personalized health care. The electroencephalogram (EEG) is a promising tool to support the diagnosis and evaluation of abnormalities in the human brain. The EEG sensors record the brain activity directly with excellent time resolution. In this study, EEG sensor with 19 electrodes were used to test the background activities of the brains of five vascular dementia (VaD), 15 stroke-related patients with mild cognitive impairment (MCI), and 15 healthy subjects during a working memory (WM) task. The objective of this study is twofold. First, it aims to enhance the recorded EEG signals using a novel technique that combines automatic independent component analysis (AICA) and wavelet transform (WT), that is, the AICA–WT technique; second, it aims to extract and investigate the spectral features that characterize the post-stroke dementia patients compared to the control subjects. The proposed AICA–WT technique is a four-stage approach. In the first stage, the independent components (ICs) were estimated. In the second stage, three-step artifact identification metrics were applied to detect the artifactual components. The components identified as artifacts were marked as critical and denoised through DWT in the third stage. In the fourth stage, the corrected ICs were reconstructed to obtain artifact-free EEG signals. The performance of the proposed AICA–WT technique was compared with those of two other techniques based on AICA and WT denoising methods using cross-correlation XCorr and peak signal to noise ratio (PSNR) (ANOVA, p ˂ 0.05). The AICA–WT technique exhibited the best artifact removal performance. The assumption that there would be a deceleration of EEG dominant frequencies in VaD and MCI patients compared with control subjects was assessed with AICA–WT (ANOVA, p ˂ 0.05). Therefore, this study may provide information on post-stroke dementia particularly VaD and stroke-related MCI patients through spectral analysis of EEG background activities that can help to provide useful diagnostic indexes by using EEG signal processing.

Alzheimer's disease: The state of the art in resting-state magnetoencephalography

Alzheimer's disease (AD) is accompanied by functional brain changes that can be detected in imaging studies, including electromagnetic activity recorded with magnetoencephalography (MEG). Here, we systematically review the studies that have examined resting-state MEG changes in AD and identify areas that lack scientific or clinical progress. Three levels of MEG analysis will be covered: (i) single-channel signal analysis, (ii) pairwise analyses over time series, which includes the study of interdependencies between two time series and (iii) global network analyses. We discuss the findings in the light of other functional modalities, such as electroencephalography (EEG) and functional magnetic resonance imaging (fMRI). Overall, single-channel MEG results show consistent changes in AD that are in line with EEG studies, but the full potential of the high spatial resolution of MEG and advanced functional connectivity and network analysis has yet to be fully exploited. Adding these features to the current knowledge will potentially aid in uncovering organizational patterns of brain function in AD and thereby aid the understanding of neuronal mechanisms leading to cognitive deficits.

Realignment of magnetoencephalographic data for group analysis in the sensor domain

Magnetoencephalography (MEG) is a neuroimaging modality with high temporal resolution for studying functional brain processes in relatively small neural assemblies on the time scale of <100 milliseconds and with synchrony and coherence in the recorded signals at high frequencies. Advanced MEG signal analysis gained importance for clinical applications, e.g., as a sensitive classifier for the diagnosis of neuropsychiatric disorders. Despite tremendous improvements in magnetic source imaging, MEG analysis often does not require explicit source estimation and can be performed in the sensor domain. However, group analysis of MEG sensor data is complicated by variable positioning of the sensor array relative to the head and needs realignment of the sensor configuration. Here, the authors provide an algorithm for transforming the magnetic field data as recorded at various sensor positions onto a common sensor array. Based on the measured magnetic field at the original sensor position, they estimate a source distribution and project it onto a virtual sensor array using the leadfield description of the magnetic forward solution. First, they analyzed the variation of sensor positioning in a typical MEG study and reported the impact on the leadfield matrix. Then they evaluated the realignment algorithm and reported its properties. Including efficient regularization to the inverse solution, they demonstrated that the introduced error is in the order of the sensor noise, and smoothing of data is limited to the set of smallest eigenvalues of the data. They demonstrated the performance of the algorithm with dipole source modeling on group averaged MEG data and comparison of grand averaged auditory evoked responses with and without sensor realignment.

Quantitative evaluation of artifact removal in real magnetoencephalogram signals with blind source separation

The magnetoencephalogram (MEG) is contaminated with undesired signals, which are called artifacts. Some of the most important ones are the cardiac and the ocular artifacts (CA and OA, respectively), and the power line noise (PLN). Blind source separation (BSS) has been used to reduce the influence of the artifacts in the data. There is a plethora of BSS-based artifact removal approaches, but few comparative analyses. In this study, MEG background activity from 26 subjects was processed with five widespread BSS (AMUSE, SOBI, JADE, extended Infomax, and FastICA) and one constrained BSS (cBSS) techniques. Then, the ability of several combinations of BSS algorithm, epoch length, and artifact detection metric to automatically reduce the CA, OA, and PLN were quantified with objective criteria. The results pinpointed to cBSS as a very suitable approach to remove the CA. Additionally, a combination of AMUSE or SOBI and artifact detection metrics based on entropy or power criteria decreased the OA. Finally, the PLN was reduced by means of a spectral metric. These findings confirm the utility of BSS to help in the artifact removal for MEG background activity.

Magnetoencephalography in neuropsychiatry: ready for application?

PURPOSE OF REVIEW

Magnetoencephalography (MEG) has been available for over 30 years, but the past 10 years have seen serious investigation of its use as a clinical tool. It is therefore an opportune time to review how MEG is able to contribute to neuropsychiatric research and practice.

RECENT FINDINGS

We limit this review to the areas of dementia, schizophrenia, depression and autism. MEG can achieve correct classification of individuals with mild cognitive impairment versus Alzheimer's disease, may identify a marker of early disease in schizophrenia, can distinguish bipolar from major depressive disorder, and has been used to study cognitive and other deficits in autism. It provides a valuable tool to study cognitive dysfunction.

SUMMARY

The most important aspect of MEG is the ability to record neural activity with millisecond precision, allowing coherence analysis of neural data to examine how brain areas are synchronized. Such synchrony is thought to underlie cognitive processes. As cognitive dysfunction is a common marker of neuropsychiatric disorders, MEG is emerging as an important investigatory tool in neuropsychiatry. It may also be useful clinically for early or differential diagnosis of some neuropsychiatric disorders, or for the prediction of drug effects, but more research is necessary before this becomes a clinical reality.

Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease

BACKGROUND & AIMS

There is a need for a reliable and inexpensive noninvasive marker of hepatic fibrosis in patients with nonalcoholic fatty liver disease (NAFLD). We compared the performance of the FIB4 index (based on age, aspartate aminotransferase [AST] and alanine aminotransferase [ALT] levels, and platelet counts) with 6 other non-invasive markers of fibrosis in patients with NAFLD.

METHODS

Using a nation-wide database of 541 adults with NAFLD, jackknife-validated areas under receiver operating characteristic curves (AUROC) of FIB4 and 7 other markers were compared. The sensitivity at 90% specificity, 80% positive predictive value, and 90% negative predictive values were determined along with cutoffs for advanced fibrosis.

RESULTS

The median FIB4 score was 1.11 (interquartile range = 0.74-1.67). The jackknife-validated AUROC for FIB4 was 0.802 (95% confidence interval [CI], 0.758-0.847), which was higher than that of the NAFLD fibrosis score (0.768; 95% CI, 0.720-0.816; P = .09), Goteburg University Cirrhosis Index (0.743; 95% CI, 0.695-0.791; P < .01), AST:ALT ratio (0.742; 95% CI, 0.690-0.794; P < .015), AST:platelet ratio index (0.730; 95% CI, 0.681-0.779; P < .001), AST:platelet ratio (0.720; 95% CI, 0.669-0.770; P < .001), body mass index, AST:ALT, diabetes (BARD) score (0.70; P < .001), or cirrhosis discriminant score (0.666; 95% CI, 0.614-0.718; P < .001). For a fixed specificity of 90% (FIB4 = 1.93), the sensitivity in identifying advanced fibrosis was only 50% (95% CI, 46-55). A FIB4 > or = 2.67 had an 80% positive predictive value and a FIB4 index < or = 1.30 had a 90% negative predictive value.

CONCLUSIONS

The FIB4 index is superior to 7 other noninvasive markers of fibrosis in patients with NAFLD; however its performance characteristics highlight the need for even better noninvasive markers.

Use of magnetoencephalography (MEG) to study functional brain networks in neurodegenerative disorders

The pathophysiological mechanisms underlying clinical symptoms in neurodegenerative disorders such as Parkinson's disease (PD) and Alzheimer's disease (AD) are incompletely understood. Magnetoencephalography (MEG) is a relatively new functional neuroimaging technique, which allows the simultaneous recording of the brain's magnetic activity from large arrays of sensors covering the whole head. MEG studies in PD and AD have identified characteristic patterns of abnormal oscillatory activity in different frequency bands. Furthermore, MEG studies aimed at the characterization of distributed functional networks have demonstrated distinct patterns of abnormal connectivity in demented and non-demented PD, as well as in AD. In PD abnormal oscillatory activity and disturbed connectivity may respond differently to dopaminergic treatment. Further studies in this field could benefit from new technological developments such as ultra low field MRI and from the application of a well-defined theoretical framework such as graph theory to the study of disturbed brain networks.

Blind source separation to enhance spectral and non-linear features of magnetoencephalogram recordings. Application to Alzheimer's disease

This work studied whether a blind source separation (BSS) and component selection procedure could increase the differences between Alzheimer's disease (AD) patients and control subjects' spectral and non-linear features of magnetoencephalogram (MEG) recordings. MEGs were acquired with a 148-channel whole-head magnetometer from 62 subjects (36 AD patients and 26 controls), who were divided randomly into training and test sets. MEGs were decomposed using the algorithm for multiple unknown signals extraction (AMUSE). The extracted AMUSE components were characterised with two spectral--median frequency and spectral entropy (SpecEn)--and two non-linear features: Lempel-Ziv complexity (LZC) and sample entropy (SampEn). One-way analysis of variance with age as a covariate was applied to the training set to decide which components had the most significant differences between groups. Then, partial reconstructions of the MEGs were computed with these significant components. In the test set, the accuracy and area under the ROC curve (AUC) associated with each partial reconstruction of the MEGs were compared with the case where no BSS-preprocessing was applied. This preprocessing increased the AUCs between 0.013 and 0.227, while the accuracy for SpecEn, LZC and SampEn rose between 6.4% and 22.6%, improving the separation between AD patients and control subjects.

Analysis of spontaneous MEG activity in Alzheimer's disease using time-frequency parameters

The aim of this study was to explore the ability of several time-frequency parameters to discriminate between spontaneous magnetoencephalographic (MEG) oscillations from 20 Alzheimer's disease (AD) patients and 21 controls. The spectral crest factor (SCF) and the spectral turbulence (ST) were calculated from the time-frequency distribution of the normalized power spectral density averaged over all MEG sensors. Results revealed statistically significant higher SCF and ST mean values for AD patients than controls (p 0.05). This fact suggests a significant decrease in irregularity of AD patients' MEG activity. The standard deviation of SCF also provided significant differences (p 0.05). This result indicates that AD patients showed a significantly higher variability than controls. The highest accuracy of 85.4% (90.5% sensitivity, 80.0% specificity) was achieved using simultaneously the mean value and the standard deviation of the SCF. We conclude that the variability of the spectral parameters can yield complementary information to the mean values, useful to help in AD detection.